Affixus Nail System for Broken Arm
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the Affixus Natural Nail System, a treatment designed to improve healing in individuals with broken upper arm bones (humerus). The main goal is to assess the safety and effectiveness of the nail system when used during surgery to stabilize these fractures. Individuals over 18 with a broken upper arm requiring surgery and who are willing to follow up with their doctor may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to medical research and potentially benefit from an innovative treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that the Affixus Nail System is safe for treating broken arms?
Research shows that the Affixus Natural Nail System is already on the market, indicating its safety. Previous studies have assessed its safety by examining the frequency and severity of side effects. No major safety issues have been reported. The system's simple and efficient design helps reduce surgical risks. Its use in real-life situations further demonstrates its safety.12345
Why are researchers excited about this trial?
The Affixus Nail System is unique because it offers a natural approach to fixing broken arms, specifically targeting fractures or osteotomies of the humerus. Unlike traditional metal plates and screws, this system uses a nail that can be inserted to stabilize the bone temporarily, potentially allowing for more natural movement and faster healing. Researchers are excited about this treatment because it promises less invasive surgery and quicker recovery times, which could significantly improve patient outcomes compared to current standard options like metal hardware.
What evidence suggests that the Affixus Nail System is effective for broken arms?
Research has shown that the Affixus Natural Nail System, which participants in this trial will receive, effectively stabilizes and fixes fractures in the humerus, the upper arm bone. This system aids proper bone healing by providing temporary support. One study found that it helps bones heal within 12 months after surgery. Patients also experienced improved arm movement, indicating good recovery. This system is popular due to its simplicity and reliability in treating arm fractures.12456
Who Is on the Research Team?
Emilie Rohmer, MSc.
Principal Investigator
Zimmer Biomet
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a broken upper arm bone needing surgery, who can follow the study's procedures and have agreed to participate. It's not for those with certain bone conditions, infections, mental or neurologic issues that prevent consent, pregnancy, or if they're unlikely to complete the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgery for the implantation of the Affixus Natural Nail System Humeral Nail
Follow-up
Participants are monitored for safety, performance, and clinical benefits, including bone union, functional outcomes, and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Affixus Natural Nail System
Affixus Natural Nail System is already approved in United States, European Union for the following indications:
- Proximal fractures (proximal short and long nails only)
- Diaphyseal fractures (proximal long, antegrade/retrograde nails)
- Open and closed fractures
- Comminuted fractures
- Nonunions and malunions
- Pathologic fractures
- Proximal fractures (proximal short and long nails only)
- Diaphyseal fractures (proximal long, antegrade/retrograde nails)
- Open and closed fractures
- Comminuted fractures
- Nonunions and malunions
- Pathologic fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business